What is EO2 Concepts?
EO2 Concepts specializes in Continuous Diffusion of Oxygen (CDO) therapy, offering advanced solutions for challenging wound healing scenarios. Their flagship product, the FDA-cleared OxyGeni system, provides continuous oxygenation and monitoring, designed for healthcare professionals including podiatrists, vascular surgeons, and plastic surgeons. The company's focus on cost-effective, naturally antibacterial wound care aims to enhance patient mobility and quality of life, while reducing the need for costly referrals and interventions.
How much funding has EO2 Concepts raised?
EO2 Concepts has raised a total of $9.1M across 5 funding rounds:
Private Equity
$732K
Private Equity
$705K
Private Equity
$2.5M
Private Equity
$4.3M
Debt
$907K
Private Equity (2009): $732K, investors not publicly disclosed
Private Equity (2009): $705K, investors not publicly disclosed
Private Equity (2010): $2.5M, investors not publicly disclosed
Private Equity (2011): $4.3M, investors not publicly disclosed
Debt (2017): $907K, investors not publicly disclosed
What's next for EO2 Concepts?
With the recent major strategic investment, EO2 Concepts is poised for significant expansion. The capital infusion is anticipated to fuel further research and development, enhance manufacturing capabilities, and broaden market penetration for their CDO therapy systems. This strategic backing suggests a strong market validation for their innovative approach to wound care, positioning the company for sustained growth and leadership in the advanced medical technology landscape. Future initiatives will likely focus on expanding clinical applications and partnerships within the healthcare ecosystem.
See full EO2 Concepts company page
